Literature DB >> 24980651

Inability to consent does not diminish the desirability of stroke thrombolysis.

Winston Chiong1, Anthony S Kim, Ivy A Huang, Nita A Farahany, S Andrew Josephson.   

Abstract

OBJECTIVE: Some have argued that physicians should not presume to make thrombolysis decisions for incapacitated patients with acute ischemic stroke because the risks and benefits of thrombolysis involve deeply personal values. We evaluated the influence of the inability to consent and of personal health-related values on older adults' emergency treatment preferences for both ischemic stroke and cardiac arrest.
METHODS: A total of 2,154 US adults age ≥50 years read vignettes in which they had either suffered an acute ischemic stroke and could be treated with thrombolysis, or had suffered a sudden cardiac arrest and could be treated with cardiopulmonary resuscitation. Participants were then asked (1) whether they would want the intervention, or (2) whether they would want to be given the intervention even if their informed consent could not be obtained. We elicited health-related values as predictors of these judgments.
RESULTS: Older adults were as likely to want stroke thrombolysis when unable to consent (78.1%) as when asked directly (76.2%), whereas older adults were more likely to want cardiopulmonary resuscitation when unable to consent (83.6% compared to 75.9%). Greater confidence in the medical system and reliance on statistical information in decision making were both associated with desiring thrombolysis.
INTERPRETATION: Older adults regard thrombolysis no less favorably when considering a situation in which they are unable to consent. These findings provide empirical support for recent professional society recommendations to treat ischemic stroke with thrombolysis in appropriate emergency circumstances under a presumption of consent.
© 2014 American Neurological Association.

Entities:  

Mesh:

Year:  2014        PMID: 24980651      PMCID: PMC4957557          DOI: 10.1002/ana.24209

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  Medicine. Do defaults save lives?

Authors:  Eric J Johnson; Daniel Goldstein
Journal:  Science       Date:  2003-11-21       Impact factor: 47.728

2.  Why are eligible thrombolysis candidates left untreated?

Authors:  Nancy K Hills; S Claiborne Johnston
Journal:  Am J Prev Med       Date:  2006-11-07       Impact factor: 5.043

3.  Testing the presumption of consent to emergency treatment for acute ischemic stroke.

Authors:  Winston Chiong; Anthony S Kim; Ivy A Huang; Nita A Farahany; S Andrew Josephson
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

4.  Out-of-hospital cardiac arrest surveillance --- Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005--December 31, 2010.

Authors:  Bryan McNally; Rachel Robb; Monica Mehta; Kimberly Vellano; Amy L Valderrama; Paula W Yoon; Comilla Sasson; Allison Crouch; Amanda Bray Perez; Robert Merritt; Arthur Kellermann
Journal:  MMWR Surveill Summ       Date:  2011-07-29

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Assessment and improvement of figures to visually convey benefit and risk of stroke thrombolysis.

Authors:  Jigneshkumar Gadhia; Sidney Starkman; Bruce Ovbiagele; Latisha Ali; David Liebeskind; Jeffrey L Saver
Journal:  Stroke       Date:  2010-01-07       Impact factor: 7.914

Review 7.  Temporal trends in acute stroke management.

Authors:  Dawn Kleindorfer; Felipe de los Rios La Rosa; Pooja Khatri; Brett Kissela; Jason Mackey; Opeolu Adeoye
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

8.  Choices of seriously ill patients about cardiopulmonary resuscitation: correlates and outcomes. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

Authors:  R S Phillips; N S Wenger; J Teno; R K Oye; S Youngner; R Califf; P Layde; N Desbiens; A F Connors; J Lynn
Journal:  Am J Med       Date:  1996-02       Impact factor: 4.965

Review 9.  Consent for intravenous thrombolysis in acute stroke: review and future directions.

Authors:  Stephanie R White-Bateman; H Christian Schumacher; Ralph L Sacco; Paul S Appelbaum
Journal:  Arch Neurol       Date:  2007-06

Review 10.  Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory del Zoppo; Peter Sandercock; Richard L Lindley; Geoff Cohen
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

View more
  5 in total

1.  Racial and Ethnic Differences in Advance Directive Possession: Role of Demographic Factors, Religious Affiliation, and Personal Health Values in a National Survey of Older Adults.

Authors:  Ivy A Huang; John M Neuhaus; Winston Chiong
Journal:  J Palliat Med       Date:  2016-02       Impact factor: 2.947

2.  Recommendations for Endovascular Care of Stroke Patients.

Authors:  Michelle Hill; Brenda A Glenn; Brenda J Reese; Benjamin Morrow
Journal:  Interv Neurol       Date:  2017-11-17

Review 3.  Trends in Recruitment Rates for Acute Stroke Trials, 1990-2014.

Authors:  William B Feldman; Anthony S Kim; Winston Chiong
Journal:  Stroke       Date:  2017-01-19       Impact factor: 7.914

Review 4.  Effect of waivers of consent on recruitment in acute stroke trials: A systematic review.

Authors:  William B Feldman; Anthony S Kim; S Andrew Josephson; Daniel H Lowenstein; Winston Chiong
Journal:  Neurology       Date:  2016-03-23       Impact factor: 9.910

5.  Choices Regarding Thrombolysis Are Modified by the Way to Transfer the Messages.

Authors:  Jingjing Gong; Yan Zhang; Hongyan Gao; Wei Wei; Jing Lv; Hongyun Liu; Yonghua Huang
Journal:  Front Neurol       Date:  2017-11-07       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.